Type 2 diabetes Nutritional, Metabolic, Endocrine Non-insulin-dependent diabetes mellitus
Conditions
Interventions
Following baseline measurements, patients will be randomly assigned to one of three groups (n=15 each):
1. Standard diabetes treatment alone (i.e. control)
2. Standard treatment and two one-hour ses
Sponsors
Arabian Gulf University (Bahrain)
Ahlia University (Bahrain)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Bahraini adults (aged 24-60 years) with type 2 diabetes (as defined by the American Diabetic Association, 1997) for more than 6 months 2. A baseline haemoglobin A1c of 6.6% to 9.9%.
Exclusion criteria
Exclusion criteria: 1. Current insulin therapy 2. Participation in exercise two or more times per week for more than or equal to 20 minutes/session during the previous 6 months 3. Changes during the previous 2 months in oral hypoglycaemic, antihypertensive or lipid-lowering agents and body weight (more than or equal to 5%) 4. Serum creatinine level of 200 µmol/L or greater 5. Proteinuria greater than 1g/d 6. Blood pressure greater than 160/95 mm Hg 7. Restrictions in physical activity because of disease 8. Presence of other medical conditions that make participation inadvisable
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in haemoglobin A1c between baseline and the end of the 12-week programme | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Pedometry (steps/day) 2. Physical activity level (International Physical Activity Questionnaire) 3. Fraction of nitric oxide in exhaled air (FeNO) to evalaute cardiorespiratory fitness 4. Body Mass Index 5. Percent body fat 6. Blood glucose Assessed at baseline, 6 and 12 weeks | — |
Countries
Bahrain
Outcome results
None listed